enVVeno Medical Corporation
NVNO
$3.63
$0.010.28%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.73% | -0.63% | -2.73% | -16.73% | -24.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.79% | -5.59% | -7.93% | -13.87% | -9.28% |
| Operating Income | 2.79% | 5.59% | 7.93% | 13.87% | 9.28% |
| Income Before Tax | 3.55% | 7.22% | 11.68% | 18.08% | 14.05% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 3.55% | 7.22% | 11.68% | 18.08% | 14.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3.55% | 7.22% | 11.68% | 18.08% | 14.05% |
| EBIT | 2.79% | 5.59% | 7.93% | 13.87% | 9.28% |
| EBITDA | 2.61% | 5.52% | 7.94% | 13.99% | 9.38% |
| EPS Basic | 30.71% | 38.20% | 43.07% | 43.78% | 33.60% |
| Normalized Basic EPS | 30.74% | 37.36% | 40.94% | 41.15% | 30.28% |
| EPS Diluted | 30.71% | 38.20% | 43.07% | 43.78% | 33.60% |
| Normalized Diluted EPS | 30.74% | 37.36% | 40.94% | 41.15% | 30.28% |
| Average Basic Shares Outstanding | 34.16% | 44.10% | 53.77% | 48.14% | 37.97% |
| Average Diluted Shares Outstanding | 34.16% | 44.10% | 53.77% | 48.14% | 37.97% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |